검 색
Interview
Articles
Industry
Info
기사 목록
March-May 2014
Merck’s Phase III tecemotide vaccine trial in NSCLC in Asian patients could show benefit, but EGFR target is unclear
AstraZeneca’s pipeline projections a tough sell, Pfizer will struggle to drive combined value
Tracking the Affordable Care Act
The Biotechnology Industry in Korea: Ripe for Investment
Dr. Phillip Frost, CEO and Chairman, OPKO Health Inc.
A Public Health Advocate for the Poor: Dr. Jong-wook Lee (1945-2006), WHO Director-General
January-February 2014
AstraZeneca’s Phase I/II AZD9291 Shows Promise in EGFR Inhibitor Refractory Patients - Oncologists
Life Science Industry’s Record-Setting Pace of Deals Unlikely to End Anytime Soon
13
/ 15
13 / 15
